About Avallano
Avallano is a Healthcare company based in Greenville (United States) founded in 2019 by Dean Rogers and Paul Della Maggiora. Clinical research platform developed for patient engagement in trials. Avallano has raised $200 thousand across 2 funding rounds from investors including SCRA. Its chief executive, as recorded, is Paul Della Maggiora. Avallano offers products and services including Clinical Research Platform and Patient Engagement App. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include IQVIA, Mural Health and Grove AI; 2 of its 3 listed competitors have raised funding.
Company details
Avallano was founded in 2019 in Greenville, United States, within the health technology sector. A platform focused on clinical trial patient engagement is operated by the company. AI-driven insights and real-world data collection are integrated to support post-trial interactions. Clinical processes are streamlined through tools for recruitment and protocol document access, serving clients in research and development.
- Headquarters Greenville, United States
- Founders Dean Rogers, Paul Della Maggiora
- SectorsHealthcare
- Phone•••• ••••
- Website avallano.com
- Social LinkedIn X Instagram
- Net Profit-$467.76 K (USD)-331as on Dec 31, 2020
- Total Equity Funding$200K (USD)
in 2 rounds
- Latest Funding Round$200K (USD), Seed
Feb 2021
- Investors
Products & Services of Avallano
Avallano offers a comprehensive portfolio of products and services, including Clinical Research Platform and Patient Engagement App.
AI tool for streamlining clinical trials and patient matching.
App for educating and engaging patients in clinical trials.
Funding Insights of Avallano
Avallano has successfully raised a total of $200K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $200 thousand completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $200,000
- Total Rounds 2
- Last Round Seed — $200,000
- First Round $50,000
(Feb 2020)
- Investors Count 1
All 2 funding rounds of Avallano with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Avallano
Avallano has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SCRA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startups are accelerated across sectors by SCRA. | 1983 | scra.org | United States |
Investor details for Avallano
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Avallano
3 people are tracked at Avallano (3 in leadership).
| Name | Role | Group |
|---|---|---|
Dean Rogers | Co-Founder | Leadership |
Paul Della Maggiora | Co-Founder & CEO | Leadership |
Michael Ibara | Chief Strategy Officer (cso) | Leadership |
Complete people profiles for Avallano
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Avallano
3 dated milestones of Avallano across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Avallano is founded.
- Funding First funding round of $50K.
- Funding Latest funding round, Seed, of $200K.
Competitors of Avallano
Avallano has 3 listed competitors in our database, 2 of them funded. They include IQVIA, Mural Health and Grove AI.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| iqvia.com | 1982 | Durham, United States | 88,000 | Clinical research and commercialization solutions are provided for healthcare. | ||
| muralhealth.com | 2022 | Menlo Park, United States | $20.73M | Clinical trial technology platform is provided for participants' streamlined experiences. | ||
| grovetrials.com | 2024 | San Francisco, United States | $4.9M | AI powered platform offering clinical trial management solutions |
Detailed competitors of Avallano
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Avallano (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Avallano
Complete news archive for Avallano
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avallano
Avallano was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Avallano is headquartered in Greenville, United States.
Paul Della Maggiora is the CEO of Avallano, as recorded in our data. They have also founded this company.
Avallano is a funded company, having raised a total of $200K across 2 funding rounds to date. The company's 1st funding round was a Grant of $50K, raised on Feb 2020.
Avallano was founded in 2019 in Greenville, United States, within the health technology sector. A platform focused on clinical trial patient engagement is operated by the company. AI-driven insights and real-world data collection are integrated to support post-trial interactions. Clinical processes are streamlined through tools for recruitment and protocol document access, serving clients in research and development.
Avallano's top competitors include IQVIA, Mural Health and Grove AI.
Avallano offers Clinical Research Platform and Patient Engagement App.
Avallano has 1 investor. Key investors include SCRA.